Testing computer-guided dosing for general anesthesia
This study tests a computerized dosing system for a sedation medicine called remimazolam during general anesthesia. It is for adults having planned surgery and aims to see if the computer-guided dosing is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 79 years old.
- You are having a planned surgery (not an emergency) that will last at least 1 hour and requires a breathing tube.
- You do not take a benzodiazepine medicine (like Valium or Xanax) every day.
- Your body mass index (BMI) is less than 35.
- You do not have chronic kidney disease, liver problems, or an allergy to the study drug (remimazolam).
- You are not pregnant and have no history of allergic reaction to flumazenil (the reversal agent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This study compares two types of anesthesia to see which one better preserves brain function and recovery after laparoscopic gallbladder removal. It aims to help patients wake up more clearly and maintain cognitive function after surgery.
This trial compares two ways of giving the sedative remimazolam during brain bypass surgery. It looks at which method uses less medicine. If you are having this surgery, you may be able to join.
This trial studies a sedative called remimazolam used during surgery on the lower body while you are awake with spinal anesthesia. It aims to find the right dose for safe and comfortable sedation during the procedure.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
Hear when a new Remimazolam trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.